|

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

RECRUITINGN/ASponsored by Johns Hopkins University
Actively Recruiting
PhaseN/A
SponsorJohns Hopkins University
Started2020-11-20
Est. completion2027-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03845205

Summary

Given the severe consequences of alcohol relapse following liver transplantation for alcoholic hepatitis (AH-LT), it is critical to accurately identify alcohol use and implement alcohol interventions early in the post-transplant period to optimize patient outcomes. The proposed randomized clinical trial will examine the implementation and effects of integrated, person- and computer-delivered alcohol treatment compared to standard care on alcohol use (assessed by self-report and biomarker), mood, quality of life and survival following AH-LT. Predictors of 12-month post-transplant alcohol outcomes will be explored to allow future improved tailoring and targeting of these treatments.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* English speaking

Exclusion Criteria:

* too medically/psychiatrically ill to participate
* not able to provide informed consent due to cognitive impairment

Conditions3

Alcohol Use DisorderAlcoholic HepatitisLiver Disease

Locations1 site

Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205
Mary E McCaul, Ph.D.410-955-9526mmccaul1@jhmi.edu

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.